Learn everything you need to know about Brivaracetam-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

On February 19, the US Food and Drug Administration (FDA) approved brivaracetam (Briviact®) for the adjunctive treatment of partial-onset seizures in patients 16 years and older. [1] Brivaracetam is ...

Please provide your email address to receive an email when new articles are posted on . A total of 37% of study participants were seizure-free for at least 6 months. The researchers noted the positive ...

An indirect comparison between lacosamide and Brivaracetam for epilepsy treatment is methodologically better and covers more outcomes than the previous indirect comparisons. However, an added benefit ...

Avoid alcohol intake while using brivaracetam since it impairs psychomotor function, attention, and memory, and it may increase side effects such as drowsiness and dizziness(1 Trusted Source ...

MUMBAI, India and NAPLES, Fla., Feb. 24, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has ...

Brussels (Belgium), 23rd July 2014 – 0700 (CEST) – regulated information – UCB today announced an important advance in its research and development pipeline with positive topline results from the ...

UCB has posted positive topline results from its latest Phase III study with its epilepsy drug brivaracetam, which will provide the basis for filings on both sides of the Atlantic early next year. UCB ...

In the randomized, double-blind, placebo-controlled, multi-center, parallel-group phase III study (N01358) UCB evaluated the efficacy and safety of brivaracetam, for a 12-week period, as an adjunctive ...

Belgian pharma company UCB has filed its investigational drug brivaracetam for approval to treat epilepsy in both the US and EU. Both the US FDA and the European Medicines Agency (EMA) have accepted ...

Brivaracetam Oral Solution (RLD Briviact) had an estimated annual sale of USD 135 million in the U.S. (IQVIA MAT December 2025). Lupin Limited is a global pharmaceutical leader headquartered in Mumbai ...